|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4422 | |
| A61K 31/44 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2214666 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08836256.1 |
| Europos patento paraiškos padavimo data | 2008-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-08-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-12-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/078786 |
| Data | 2008-10-03 |
| (87) | Numeris | WO 2009/046323 |
| Data | 2009-04-09 |
| (30) | Numeris | Data | Šalis |
| 977953 P | 2007-10-05 | US | |
| 46109 | 2008-04-18 | US |
| (72) |
MULLAN, Michael, J., US
PARIS, Daniel, US
IVEY, Robert, A., III, US
|
| (73) |
Alzheimer`s Institute of America, Inc.,
7837 Parallel Parkway, Kansas City, KS 66112,
US
|
| (54) | METHOD FOR REDUCING AMYLOID DEPOSITION, AMYLOID NEUROTOXICITY, AND MICROGLIOSIS WITH (-)-NILVADIPINE ENANTIOMER |
| METHOD FOR REDUCING AMYLOID DEPOSITION, AMYLOID NEUROTOXICITY, AND MICROGLIOSIS WITH (-)-NILVADIPINE ENANTIOMER |